Browse Category

Cannabis Industry News 8 October 2025 - 14 November 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (NASDAQ: AKAN) is back in the news today after outlining the next steps toward a full Health Canada cultivation license at its British Columbia cannabis site, while commentators highlight the company’s unusual mix of Mexican telecom infrastructure and Canadian cannabis “optionality.” Newsfile+1 A fresh Newsfile press release this morning details how Akanda will design and implement Health Canada–compliant security at its Gabriola Island facility, a prerequisite for producing THC- and CBD-rich cannabis under a full cultivation license. Newsfile+1 At the same time, a new MarketScreener feature frames Akanda as a “dual‑track” small cap: cash flow from towers and
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth Corporation (NASDAQ: CGC; TSX: WEED) reported second‑quarter fiscal 2026 results today that highlight improving operations, tighter cost control, and a stronger balance sheet. The company ended the quarter with C$298 million in cash and cash equivalents, exceeding total debt by C$70 million—and said the conditions that had previously raised “substantial doubt” about its ability to continue as a going concern have been resolved. Canopy Growth Market reaction Investors initially cheered the update: CGC rose ~19% in premarket trading after the release. Shares have since been volatile through the session. Seeking Alpha By the numbers (Q2 FY2026, quarter ended
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. (NASDAQ: SNDL), one of Canada’s largest cannabis and liquor retailers, just released its third-quarter 2025 results, sending its stock price tumbling. Below is a summary of key facts, followed by an in-depth analysis of the latest news, financials, expert opinions, forecasts, and how SNDL compares to peers in the cannabis sector. Recent News and Developments (Late Oct – Early Nov 2025) In the days surrounding the Q3 earnings release, SNDL Inc. was in the headlines for several reasons: In summary, the recent news cycle for SNDL has been dominated by its earnings announcement and the market’s reaction. Now
From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride

From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride

Market Analysis & Forecast: For now, analysts and investors appear in “wait and see” mode. Near-term catalysts will be pivotal. These include the finalization (or not) of the Antalpha $250M convertible deal – which would inject capital but on what terms? – and the company’s next earnings report (to show if core healthcare revenue is growing or still minuscule). If Bitcoin’s price continues to climb in late 2025, it could boost KindlyMD’s asset value and perhaps its stock; conversely, a crypto downturn or interest rate spike could hurt both the value of its BTC and its ability to raise funds
Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Merger with Flash Sports & Media Sparks Stock Surge Urban-gro’s announcement of a planned merger with Flash Sports & Media sent its battered stock soaring on October 14. The company revealed it signed a binding LOI to combine with Flash, a private sports-media firm, in what is effectively a reverse merger tipranks.com. Under the proposal, Flash will be absorbed into new Urban-gro subsidiaries, and Flash’s shareholders will receive new Urban-gro shares (unregistered) equal to 19.99% of UGRO’s pre-merger common stock, plus a new series of preferred shares that convert to common upon shareholder approval sec.gov sec.gov. Once the dust settles,
Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s Strong Quarter Signals a Turnaround Tilray Brands kicked off its fiscal 2026 with better-than-expected results, signaling that aggressive cost-cutting and diversification efforts are bearing fruit. The company’s Q1 FY2026 revenue hit $209.5 million, a 5% increase over last year’s quarter stocktitan.net. More impressively, Tilray managed to swing to a net profit of $1.5 million (or $0.00 per share) – a stark improvement from the -$34.7 million loss in the prior-year period stocktitan.net stocktitan.net. This marks one of Tilray’s first profitable quarters since its 2018 IPO, a milestone achieved through tighter operational discipline. Adjusted EBITDA came in at $10.2 million
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray’s Stock Price Soars on Reform Speculation Tilray’s stock has been on a tear in recent months, staging a stunning turnaround from penny-stock levels. The share price has quadrupled since early July – rising from well under $0.5 to around $1.7 by early October nasdaq.com. Year-to-date, TLRY is up ~22% (as of Oct. 8) after being down over 20% mid-year talkmarkets.com hi-plainscoop.com. This rebound has rescued Tilray from the brink of a Nasdaq delisting – the company had even sought a compliance extension when its shares languished below $1 in the summer hi-plainscoop.com. The rally hit overdrive in late September 2025. On September 29, Tilray skyrocketed 42%
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Recent News & Stock Performance (October 2025) Tilray’s stock has been on a wild ride in early October 2025, propelled by a flurry of cannabis policy news. In the first week of October, TLRY jumped over 8% in one day (Oct 7) after an apparent breakthrough in U.S. marijuana reform sentiment nasdaq.com nasdaq.com. The trigger: several prominent Republican senators voiced unexpected support for easing federal cannabis laws, and former President Donald Trump – now in his second term – signaled openness to rescheduling marijuana. MarijuanaMoment reports that in late September, Trump shared a video touting CBD’s health benefits for seniors,
Go toTop